Suppr超能文献

新型隐球菌荚膜大小的实验性调控

Experimental modulation of capsule size in Cryptococcus neoformans.

作者信息

Zaragoza Oscar, Casadevall Arturo

机构信息

Department of Microbiology and Immunology, Albert Einstein College of Medicine. 1300 Morris Park Avenue, Bronx, New York 10461. USA.

出版信息

Biol Proced Online. 2004;6:10-15. doi: 10.1251/bpo68. Epub 2004 Mar 3.

Abstract

Experimental modulation of capsule size is an important technique for the study of the virulence of the encapsulated pathogen Cryptococcus neoformans. In this paper, we summarize the techniques available for experimental modulation of capsule size in this yeast and describe improved methods to induce capsule size changes. The response of the yeast to the various stimuli is highly dependent on the cryptococcal strain. A high CO(2) atmosphere and a low iron concentration have been used classically to increase capsule size. Unfortunately, these stimuli are not reliable for inducing capsular enlargement in all strains. Recently we have identified new and simpler conditions for inducing capsule enlargement that consistently elicited this effect. Specifically, we noted that mammalian serum or diluted Sabouraud broth in MOPS buffer pH 7.3 efficiently induced capsule growth. Media that slowed the growth rate of the yeast correlated with an increase in capsule size. Finally, we summarize the most commonly used media that induce capsule growth in C. neoformans.

摘要

实验性调节荚膜大小是研究隐球菌属病原体新型隐球菌毒力的一项重要技术。在本文中,我们总结了可用于实验性调节该酵母荚膜大小的技术,并描述了诱导荚膜大小变化的改进方法。酵母对各种刺激的反应高度依赖于隐球菌菌株。高二氧化碳气氛和低铁浓度传统上用于增大荚膜大小。不幸的是,这些刺激对于诱导所有菌株的荚膜增大并不可靠。最近,我们发现了诱导荚膜增大的新的更简单条件,这些条件能持续引发这种效应。具体而言,我们注意到哺乳动物血清或pH 7.3的MOPS缓冲液中的稀释沙氏肉汤能有效诱导荚膜生长。减缓酵母生长速率的培养基与荚膜大小增加相关。最后,我们总结了在新型隐球菌中诱导荚膜生长最常用的培养基。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b197/389900/f8e57111863a/bpo_v6_p10_m68f1lg.jpg

相似文献

1
Experimental modulation of capsule size in Cryptococcus neoformans.
Biol Proced Online. 2004;6:10-15. doi: 10.1251/bpo68. Epub 2004 Mar 3.
2
Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2).
Infect Immun. 2003 Nov;71(11):6155-64. doi: 10.1128/IAI.71.11.6155-6164.2003.
3
Capsule Enlargement in Is Dependent on Mitochondrial Activity.
Front Microbiol. 2017 Jul 31;8:1423. doi: 10.3389/fmicb.2017.01423. eCollection 2017.
4
Magnesium Ion Acts as a Signal for Capsule Induction in Cryptococcus neoformans.
Front Microbiol. 2016 Mar 15;7:325. doi: 10.3389/fmicb.2016.00325. eCollection 2016.
5
Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans.
J Vis Exp. 2018 Feb 27(132):57171. doi: 10.3791/57171.
6
Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide.
J Clin Invest. 1985 Aug;76(2):508-16. doi: 10.1172/JCI112000.
8
Quantification of C. neoformans Capsule Diameter.
Methods Mol Biol. 2024;2775:225-237. doi: 10.1007/978-1-0716-3722-7_15.
9
The Capsule of Cryptococcus neoformans Modulates Phagosomal pH through Its Acid-Base Properties.
mSphere. 2018 Oct 24;3(5):e00437-18. doi: 10.1128/mSphere.00437-18.

引用本文的文献

1
Ubiquitin degradation of the Ribonuclease H2 subunit B Rnh2B regulates the virulence of .
Virulence. 2025 Dec;16(1):2554303. doi: 10.1080/21505594.2025.2554303. Epub 2025 Aug 31.
2
The Hidden Fortress: A Comprehensive Review of Fungal Biofilms with Emphasis on .
J Fungi (Basel). 2025 Mar 19;11(3):236. doi: 10.3390/jof11030236.
3
Effects of human immunoglobulin A on morphology and gene expression.
Microbiol Spectr. 2025 Apr;13(4):e0200824. doi: 10.1128/spectrum.02008-24. Epub 2025 Feb 21.
4
Role of the Anaphase-Promoting Complex Activator Cdh1 in the Virulence of .
J Fungi (Basel). 2024 Dec 23;10(12):891. doi: 10.3390/jof10120891.
7
Phosphate availability conditions caspofungin tolerance, capsule attachment and titan cell formation in .
Front Fungal Biol. 2024 Aug 14;5:1447588. doi: 10.3389/ffunb.2024.1447588. eCollection 2024.
9
Quantification of C. neoformans Capsule Diameter.
Methods Mol Biol. 2024;2775:225-237. doi: 10.1007/978-1-0716-3722-7_15.
10
Corrected and republished from: "Extracellular Vesicle Formation in Impacts Fungal Virulence".
Infect Immun. 2024 Apr 9;92(4):e0003724. doi: 10.1128/iai.00037-24. Epub 2024 Mar 12.

本文引用的文献

1
Cryptococcus neoformans IV. The Not-So-Encapsulated Yeast.
Infect Immun. 1970 Jun;1(6):526-31. doi: 10.1128/iai.1.6.526-531.1970.
2
Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2).
Infect Immun. 2003 Nov;71(11):6155-64. doi: 10.1128/IAI.71.11.6155-6164.2003.
3
Capsule synthesis by Cryptococcus neoformans.
Trans N Y Acad Sci. 1958 May;20(7):623-48. doi: 10.1111/j.2164-0947.1958.tb00625.x.
6
Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection.
Microbiology (Reading). 2001 Aug;147(Pt 8):2355-2365. doi: 10.1099/00221287-147-8-2355.
7
Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans.
Mol Cell Biol. 2001 May;21(9):3179-91. doi: 10.1128/MCB.21.9.3179-3191.2001.
9
Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection.
Infect Immun. 1998 Oct;66(10):5027-30. doi: 10.1128/IAI.66.10.5027-5030.1998.
10
Discordant regulation of phenoloxidase and capsular polysaccharide in Cryptococcus neoformans.
J Med Vet Mycol. 1996 Jul-Aug;34(4):289-91. doi: 10.1080/02681219680000491.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验